SEC Tracker
Get the app

Supernus Pharmaceuticals

Supernus Pharmaceuticals shares held by Bethany Sensenig

Bethany Sensenig (Director) reported option or other derivative trades in SUPN

Form
4
Filed
Importance
Routine
  1. Director Stock Option with price $30.22
  2. 8,252 shares vested on Feb 22, 2034
  3. Restricted Stock Unit (shares paid out over time) of 2,989 shares
  4. Options vesting through Feb 18, 2036

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Supernus Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Sarepta Therapeutics SRPT public float $1.7B, Jun 30, 2025
  2. Amicus Therapeutics FOLD public float $1.7B, Jun 30, 2025
  3. Ocular Therapeutix OCUL public float $1.6B, Jun 30, 2025
  4. Ligand Pharmaceuticals LGND public float $1.6B, Jun 30, 2025
  5. Apellis Pharmaceuticals APLS public float $1.8B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.